News and Insights

Cancer treatment and the time spent traveling for care are often very time-consuming. By recognizing and working to decrease time toxicity for patients with cancer, we can lessen their burden.

Barriers related to implantable devices often keep orthopedic procedures from being peformed outside the hospital.

Joint offering will seek to to enable more coordinated, connected and empowered journeys for people living with cancer in the U.S.

Evolent's Dr. Kamal Golla speaks with the Healthcare Finance Management Association’s Voices podcast about the challenges of connecting primary and specialty care.

Our CMO, Dr. Andrew Hertler, talks to Yahoo Life about identifying which patients need genetic testing or aggressive cancer screening, the issues surrounding prophylactic surgery, and more.

Dr. Andrew Hertler discussed the importance of prophylactic mastectomy for individuals carrying BRCA1, BRCA2 and other deleterious mutations.

Our CMO speaks with Urban Health Today about who should get screened, the role of primary care physicians in identifying at-risk individuals, and more.

Our vice president of pharmacy explores the hard-to-predict impacts of drug price negotiations on consumers, plans and pharmaceutical companies.

Two Evolent experts discuss the benefits of genetic testing in oncology in American Journal of Managed Care.

Evolent takes a multifaceted approach to help providers navigate shortages of cisplatin, carboplatin and other anti-cancer drugs.

Evolent is leveraging our expertise in two key specialties to reduce cardiovascular damage related to cancer drugs.

Evolent addresses a startling difference in what men and women pay for the same drug.

An Evolent program reduces unnecessary radiation treatments for breast cancer without compromising efficacy.

Evolent's Connie Ducaine writes in MarketWatch that patients need to be proactive to ensure their preferences for end of life are respected.

Our evidence-driven, patient-first model helps produce more informed decisions.

Our solutions are coming together under one brand to improve outcomes for people with complex health conditions.